These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 373696)

  • 1. Cell migration studies in human renal allograft recipients.
    Skopińska E; Gradowska L; Wojtulewicz-Kurkus J; Lao M; Wasik M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):981-6. PubMed ID: 373696
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of correlation between inhibitory or stimulatory influence of kidney antigens on in vitro leukocyte and lymphocyte migration in renal-transplanted patients.
    Skopińska-Rózewska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):499-504. PubMed ID: 7036935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro study of renal allograft recipients for cellular delayed type hypersensitivity to glomerular basement membrane and disrupted spleen cells.
    House AK; Boak JL; Hulme B
    Clin Exp Immunol; 1972 Jun; 11(2):165-72. PubMed ID: 4557180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte migration inhibition with spleen extracts and other antigens in patients with renal allografts.
    Dormont J; Sobel A; Galanaud P; Crevon MC; Colombani J
    Transplant Proc; 1972 Jun; 4(2):265-9. PubMed ID: 4113699
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of kidney allograft rejection.
    Najarian JS; Foker JE
    Transplant Proc; 1969 Mar; 1(1):184-93. PubMed ID: 4944216
    [No Abstract]   [Full Text] [Related]  

  • 6. The genesis of glomerulonephritis in renal transplants.
    Merrill JP
    Adv Nephrol Necker Hosp; 1971; 1():65-73. PubMed ID: 5006259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular reactivity studies in human and experimental renal transplantation.
    Zabriskie JB; Read SE; Ellis RJ; Markowitz AS; Rappaport FT
    Transplant Proc; 1972 Jun; 4(2):259-64. PubMed ID: 4556067
    [No Abstract]   [Full Text] [Related]  

  • 8. Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin.
    Wilson CB; Dixon FJ; Fortner JG; Cerilli GJ
    J Clin Invest; 1971 Jul; 50(7):1525-35. PubMed ID: 4996886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens.
    de Heer E; Davidoff A; van der Wal A; van Geest M; Paul LC
    Lab Invest; 1994 Apr; 70(4):494-502. PubMed ID: 8176888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte migration test and renal allograft rejection.
    Galanaud P; Crevon MC; Dormont J; Mathieu P; Weydert A
    Transplantation; 1972 Jan; 13(1):48-52. PubMed ID: 4550347
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of ATG treatment on LyMIF and LyMSF production in mixed lymphocyte cultures of rabbits after renal allotransplantation.
    Skopińska E; Wasik M; Mościcka-Wesołowska M; Wojtulewicz-Kurkus J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):987-9. PubMed ID: 155435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients.
    Falk RE; Guttmann RD; Falk JA; Beaudoin JG; Deveber G; Morehouse DD; Wilson DR
    Clin Exp Immunol; 1973 May; 14(1):47-56. PubMed ID: 4577287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intermittent hemodialysis on the immune response of potential renal allograft recipients, and its correlation with allograft survival.
    Rashid A; Sengar DP; Couture RA; Posen GA; Harris JE
    Trans Am Soc Artif Intern Organs; 1974; 20 B():557-61. PubMed ID: 4615413
    [No Abstract]   [Full Text] [Related]  

  • 15. The participation of complement in renal disease and allograft rejection as assessed by model animal systems.
    Cooper NR; Cochrane CG
    Transplant Proc; 1974 Mar; 6(1):51-7. PubMed ID: 4593654
    [No Abstract]   [Full Text] [Related]  

  • 16. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of cell-mediated immunity to transplantation antigens in human renal allograft recipients.
    Falk RE; Guttmann RD; Falk JA; DeVeber G; Wilson DR; Beaudoin JG; Morehouse DD
    Transplant Proc; 1972 Jun; 4(2):271-3. PubMed ID: 4556068
    [No Abstract]   [Full Text] [Related]  

  • 18. Effector T-cell repertoire selection in human allograft rejection.
    Finn OJ; Miceli MC
    Transplant Proc; 1989 Feb; 21(1 Pt 1):346-8. PubMed ID: 2495608
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravascular coagulation (IVC) in human renal allograft rejection.
    Busch GJ; Braun WE; Carpenter CB; Corson JM; Galvanek ER; Reynolds ES; Merrill JP; Dammin GJ
    Transplant Proc; 1969 Mar; 1(1):267-70. PubMed ID: 4944225
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of renal allograft rejection].
    Michel F
    Ann Urol (Paris); 1988; 22(3):161-7. PubMed ID: 3041909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.